Inhibition of diverse opportunistic viruses by structurally optimized retrograde trafficking inhibitors

Dhimant Desai, Matthew Lauver, Alexandria Ostman, Linda Cruz, Kevin Ferguson, Ge Jin, Brianne Roper, Daniel Brosius, Aron Lukacher, Shantu Amin, Nicholas Buchkovich

Research output: Contribution to journalArticle

Abstract

Opportunistic viruses are a major problem for immunosuppressed individuals, particularly following organ or stem cell transplantation. Current treatments are non-existent or suffer from problems such as high toxicity or development of resistant strains. We previously published that a trafficking inhibitor that targets a host protein greatly reduces the replication of human cytomegalovirus. This inhibitor was also shown to be moderately effective against polyomaviruses, another family of opportunistic viruses. We have developed a panel of analogues for this inhibitor and have shown that these analogues maintain their high efficacy against HCMV, while substantially lowering the concentration required to inhibit polyomavirus replication. By targeting a host protein these compounds are able to inhibit the replication of two very different viruses. These observations open up the possibility of pan-viral inhibitors for immunosuppressed individuals that are effective against multiple, diverse opportunistic viruses.

Original languageEnglish (US)
Pages (from-to)1795-1803
Number of pages9
JournalBioorganic and Medicinal Chemistry
Volume27
Issue number9
DOIs
StatePublished - May 1 2019

Fingerprint

Viruses
Polyomavirus
Stem Cell Transplantation
Stem cells
Cytomegalovirus
Toxicity
Proteins
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Desai, Dhimant ; Lauver, Matthew ; Ostman, Alexandria ; Cruz, Linda ; Ferguson, Kevin ; Jin, Ge ; Roper, Brianne ; Brosius, Daniel ; Lukacher, Aron ; Amin, Shantu ; Buchkovich, Nicholas. / Inhibition of diverse opportunistic viruses by structurally optimized retrograde trafficking inhibitors. In: Bioorganic and Medicinal Chemistry. 2019 ; Vol. 27, No. 9. pp. 1795-1803.
@article{8943faaa8a2e495fba5e1058337fbd3e,
title = "Inhibition of diverse opportunistic viruses by structurally optimized retrograde trafficking inhibitors",
abstract = "Opportunistic viruses are a major problem for immunosuppressed individuals, particularly following organ or stem cell transplantation. Current treatments are non-existent or suffer from problems such as high toxicity or development of resistant strains. We previously published that a trafficking inhibitor that targets a host protein greatly reduces the replication of human cytomegalovirus. This inhibitor was also shown to be moderately effective against polyomaviruses, another family of opportunistic viruses. We have developed a panel of analogues for this inhibitor and have shown that these analogues maintain their high efficacy against HCMV, while substantially lowering the concentration required to inhibit polyomavirus replication. By targeting a host protein these compounds are able to inhibit the replication of two very different viruses. These observations open up the possibility of pan-viral inhibitors for immunosuppressed individuals that are effective against multiple, diverse opportunistic viruses.",
author = "Dhimant Desai and Matthew Lauver and Alexandria Ostman and Linda Cruz and Kevin Ferguson and Ge Jin and Brianne Roper and Daniel Brosius and Aron Lukacher and Shantu Amin and Nicholas Buchkovich",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.bmc.2019.03.026",
language = "English (US)",
volume = "27",
pages = "1795--1803",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "9",

}

Inhibition of diverse opportunistic viruses by structurally optimized retrograde trafficking inhibitors. / Desai, Dhimant; Lauver, Matthew; Ostman, Alexandria; Cruz, Linda; Ferguson, Kevin; Jin, Ge; Roper, Brianne; Brosius, Daniel; Lukacher, Aron; Amin, Shantu; Buchkovich, Nicholas.

In: Bioorganic and Medicinal Chemistry, Vol. 27, No. 9, 01.05.2019, p. 1795-1803.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Inhibition of diverse opportunistic viruses by structurally optimized retrograde trafficking inhibitors

AU - Desai, Dhimant

AU - Lauver, Matthew

AU - Ostman, Alexandria

AU - Cruz, Linda

AU - Ferguson, Kevin

AU - Jin, Ge

AU - Roper, Brianne

AU - Brosius, Daniel

AU - Lukacher, Aron

AU - Amin, Shantu

AU - Buchkovich, Nicholas

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Opportunistic viruses are a major problem for immunosuppressed individuals, particularly following organ or stem cell transplantation. Current treatments are non-existent or suffer from problems such as high toxicity or development of resistant strains. We previously published that a trafficking inhibitor that targets a host protein greatly reduces the replication of human cytomegalovirus. This inhibitor was also shown to be moderately effective against polyomaviruses, another family of opportunistic viruses. We have developed a panel of analogues for this inhibitor and have shown that these analogues maintain their high efficacy against HCMV, while substantially lowering the concentration required to inhibit polyomavirus replication. By targeting a host protein these compounds are able to inhibit the replication of two very different viruses. These observations open up the possibility of pan-viral inhibitors for immunosuppressed individuals that are effective against multiple, diverse opportunistic viruses.

AB - Opportunistic viruses are a major problem for immunosuppressed individuals, particularly following organ or stem cell transplantation. Current treatments are non-existent or suffer from problems such as high toxicity or development of resistant strains. We previously published that a trafficking inhibitor that targets a host protein greatly reduces the replication of human cytomegalovirus. This inhibitor was also shown to be moderately effective against polyomaviruses, another family of opportunistic viruses. We have developed a panel of analogues for this inhibitor and have shown that these analogues maintain their high efficacy against HCMV, while substantially lowering the concentration required to inhibit polyomavirus replication. By targeting a host protein these compounds are able to inhibit the replication of two very different viruses. These observations open up the possibility of pan-viral inhibitors for immunosuppressed individuals that are effective against multiple, diverse opportunistic viruses.

UR - http://www.scopus.com/inward/record.url?scp=85062893232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062893232&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2019.03.026

DO - 10.1016/j.bmc.2019.03.026

M3 - Article

VL - 27

SP - 1795

EP - 1803

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 9

ER -